Company profile: Pharmia
1.1 - Company Overview
Company description
- Provider of nutritional supplements and healthcare supplies, developing and manufacturing products and specializing in product development. The company continually innovates, researches, and develops new compositions, flavors, and product applications, serving companies that market food supplements in Finland.
Products and services
🔒
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Pharmia
Cambrian Bio
HQ: United States
Website
- Description: Provider of therapeutics to lengthen healthspan via a Distributed Development Company model, advancing programs targeting biological drivers of aging, including ATX-304 (a pan-AMPK activator for cardiometabolic diseases, Phase 1B), Tornado Therapeutics (developing mTOR inhibitors with novel selectivity profiles), and Telovance (a protein complex to enhance ex-vivo cell therapy expansion).
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Cambrian Bio company profile →
Tetris Pharma
HQ: United Kingdom
Website
- Description: Provider of a pan-European platform to market a range of prescription products, offered by a UK-based speciality pharmaceutical company with extensive experience of launching products in the UK and across Europe, focused on areas of unmet clinical need.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Tetris Pharma company profile →
Qualicaps
HQ: United States
Website
- Description: Provider of two-piece empty pharmaceutical capsules and processing equipment, including gelatin capsules for oral dosage forms and dry powder inhalers; plant-based hypromellose capsules suited to moisture-sensitive APIs; inhalation capsules with superior aerosolization; and capsule filling, band-sealing, and visual inspection machines for precision, integrity, and quality control.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Qualicaps company profile →
Triangle Insights Group
HQ: United States
Website
- Description: Provider of strategy consulting services to life sciences organizations, guiding leaders on critical business issues with deep industry knowledge. Offerings include pricing and market access, commercial strategy and execution, R&D prioritization, commercial launch strategy, due diligence, and portfolio strategy.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Triangle Insights Group company profile →
Adams Clinical
HQ: United States
Website
- Description: Provider of late-phase psychiatric and neurologic clinical trials in Massachusetts, conducting double-blind, randomized, placebo-controlled studies on investigational drugs. Also runs open-label depression monitoring (TRAIT-MDD-107) and Alzheimer's studies: ABBV-552 (M23-515 AbroAD) for mild AD and remternetug (J1G-MC-LAKC TRAILRUNNER-ALZ-1) for early symptomatic AD.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Adams Clinical company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Pharmia
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Pharmia
2.2 - Growth funds investing in similar companies to Pharmia
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Pharmia
4.2 - Public trading comparable groups for Pharmia
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →